JP Stock MarketDetailed Quotes

4506 Sumitomo Pharma

Watchlist
  • 420
  • -3-0.71%
20min DelayMarket Closed Jul 19 15:00 JST
167.12BMarket Cap-529P/E (Static)

Sumitomo Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sumitomo Pharma Earnings Date

Currency: JPY

Period

Q1 FY2025 Estimates

Jul 31, 2024

Revenue(YoY)

82.16B

+8.54%
EPS(YoY)

-13.20

+86.51%
Analyst Rating

Underperform

Jun 18, 2024

Sumitomo Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 80.800B--
Jul 31, 20242025/Q1-- / 82.162B--
May 14, 20242024/Q479.530B / 79.948B--
Jan 31, 20242024/Q382.386B / 91.700B--
Oct 31, 20232024/Q276.942B / 92.800B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 80.800B--
Jul 31, 20242025/Q1-- / 82.162B--
May 14, 20242024/Q479.530B / 79.948B--
Jan 31, 20242024/Q382.386B / 91.700B--
Oct 31, 20232024/Q276.942B / 92.800B--

Unlock Free Earnings Estimates

Sumitomo Pharma Earnings Reports

  • Sumitomo Pharma: Confirmation letter

    Jul 3 03:32 ET

  • Sumitomo Pharma: Correction of Securities Report - 204th period (April 01, 2023 - March 31, 2024)

    Jul 3 03:23 ET

  • Sumitomo Pharma: Interim report

    Jun 26 02:44 ET

  • Sumitomo Pharma: Confirmation letter

    Jun 25 03:58 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 18, 2024

    Underper form

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      50.00%

    • Underperform

      12.50%

    • Sell

      37.50%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg